Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-LONG trial of rFVIIIFc in severe hemophilia A
2010-020558-33Phase 2Completed
- Sponsor
- Biogen
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of Factor VIII in hemophilia A (5 arms), sponsored by Biogen. Primary endpoints: Safety and tolerability and Pharmacokinetic profile. Started Jan 2011; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2010-020558-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020558-33.